Cytokines and troponin-I in cardiac dysfunction after coronary artery grafting with cardiopulmonary bypass

Arq Bras Cardiol. 2001 Aug;77(2):107-19. doi: 10.1590/s0066-782x2001000800002.
[Article in English, Portuguese]

Abstract

Objective: The association between cytokines and troponin-I with cardiac function after cardiac surgery with cardiopulmonary bypass remains a topic of continued investigation.

Methods: Serial measurements, within 24h following surgery, of tumor necrosis factor-alpha, its soluble receptors, and troponin-I were performed in patients with normal ejection fraction undergoing coronary artery bypass grafting. Ejection fraction was measured by radioisotopic ventriculography preoperatively, at 24h and at day 7 postoperatively.

Results: Of 19 patients studied (59+/-8.5 years), 10 (group 1) showed no changes in ejection fraction, 53+/-8% to 55+/-7%, and 9 (group 2) had a decrease in ejection fraction, 60+/-11% to 47+/-11% (p=0.015) before and 24h after coronary artery bypass grafting, respectively. All immunological variables, except tumor necrosis factor-alpha soluble receptor I at 3h postoperation (5.5+/- 0.5 in group 1 versus 5.9+/-0.2 pg/ml in group 2; p=0.048), were similar between groups. Postoperative troponin-I had an inverse correlation with ejection fraction at 24h (r= -0.44).

Conclusions: Inflammatory activity, assessed based on tumor necrosis factor-alpha and its receptors, appears to play a minor role in cardiac dysfunction after cardiac surgery. Troponin I levels are inversely associated with early postoperative ejection fraction.

MeSH terms

  • Biomarkers / blood
  • Cytokines / blood*
  • Extracorporeal Circulation* / adverse effects
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Revascularization*
  • Postoperative Complications / blood*
  • Postoperative Complications / diagnosis
  • Receptors, Tumor Necrosis Factor / blood
  • Stroke Volume
  • Troponin I / blood*
  • Tumor Necrosis Factor-alpha / metabolism*
  • Ventricular Dysfunction / blood
  • Ventricular Dysfunction / diagnosis

Substances

  • Biomarkers
  • Cytokines
  • Receptors, Tumor Necrosis Factor
  • Troponin I
  • Tumor Necrosis Factor-alpha